Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- Advisory bodies and committees (219)
- Scheduling (national classification system) (59)
- Therapeutic goods regulation (43)
- Regulatory compliance (27)
- In Vitro Diagnostic medical devices (IVDs) (26)
- Manufacturing (26)
- Prescription medicines (24)
- Advertising (22)
- Non-prescription medicines (20)
- Unique Device Identification (UDI) hub (20)
- Registered complementary medicines (17)
- Complementary medicines (16)
- COVID-19 vaccines (14)
- Over the counter (OTC) medicines (10)
- Safety (10)
- Australian Register of Therapeutic Goods (ARTG) (9)
- Clinical trials (9)
- Medical devices safety (9)
- Legislation (8)
- Medicine safety (8)
- Vaping hub (8)
- Medicinal cannabis hub (5)
- Listed medicines (3)
- Shortages (3)
- Advanced therapies (2)
- Breast implant hub (2)
- Compliance and enforcement hub (2)
- Pharmacovigilance (2)
- Alert/Advisory (1)
- Blood and blood components (1)
- Cosmetics (1)
- Import and export (1)
- Labelling and packaging (1)
- TGA conformity assessment certification (1)
Search
452 result(s) found, displaying 126 to 150
-
PresentationsThe final webinar in this series will explore the impact changes to the EU MDR will have on consent to supply and market notifications.
-
Committee meetingsAdvisory Committee on Medical Devices (ACMD) meeting
-
WebinarsThis webinar will focus on how the changes under the EU MDR will affect manufacturer evidence and variations to the ARTG.
-
WebinarsChanges to the formatting and structure of the Poisons Standard will come into effect from 1 February 2023
-
PresentationsThis is the second in a series of three educational webinars outlining what regulatory actions are required as a result of changes under the EU MDR, with a focus on manufacturer evidence and variations to the ARTG.
-
PresentationsPresentation on the new formatting and structure of the Poisons Standard
-
WebinarsThis webinar will outline what regulatory actions are required as a result of changes under the EU MDR, and how the TGA will streamline the transition.
-
PresentationsThis is the first in a series of three educational webinars outlining what regulatory actions are required as a result of changes under the EU MDR.
-
Committee meetingsTherapeutic Goods Advertising Consultative Committee
-
-
Committee meetingsThe 40th meeting of the Advisory Committee on Medicines Scheduling (ACMS #40), November 2022.
-
Committee meetingsThe 35th meeting of the Advisory Committee on Chemicals Scheduling (ACCS #35), November 2022.
-
Committee meetingsAdvisory Committee on Biologicals (ACB) meeting
-
Committee meetingsThe 32nd joint meeting of the Advisory Committee on Medicines Scheduling and Chemicals Scheduling (Joint ACMS-ACCS #32), November 2022.
-
Committee meetingsAdvisory Committee on Complementary Medicines (ACCM) meeting
-
PresentationsPresentation at the RACI Pharmaceutical Science Group (NSW) Seminar/Webinar, information for manufacturers of medicinal products on Computerised Systems - establishing and maintaining data integrity
-
WebinarsA webinar covering how to view and respond to notifications in the Consent for Non-compliance Dashboard
-
PresentationsThis webinar will cover the process of submitting evidence of compliance with the EPs for devices in a consent application in a live demonstration.
-
WebinarsA webinar covering medical device that are non-compliant with the Essential Principles (EPs)
-
PresentationsThis webinar will guide you through the process of applying for consent to import, supply or export a medical device non-compliant with the Essential Principles (EPs)
-
PresentationsGuest speakers from Zebra Technologies will share observations and learnings from the UK Scan4Safety pilot.
-
WebinarsGuest speakers from Zebra Technologies will share observations and learnings from the UK Scan4Safety pilot.
-
Committee meetingsAdvisory Committee on Medical Devices (ACMD) meeting
-
-
Committee meetingsAustralian Influenza Vaccine Committee (AIVC) meeting